Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
Takeda launched a restructuring. Innovent notched positive data for a GLP-1R/GCGR agonist. BIO warned of the harm from cutting off Chinese CDMOs.
Angus Liu
May 10, 2024 9:30am
Sponsored
Ensuring your HCP engagement model is up to task as brands mature
May 6, 2024 8:00am
A series on advancements in cell & gene therapy manufacturing
May 10, 2024 8:54am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Salix runs Xifaxan TV spot with 'Scandal' actor Bellamy Young
May 10, 2024 4:45am
Argenx isn't sweating over Vyvgart competitors: exec
May 9, 2024 4:56pm
Manufacturing News
BIO survey finds sudden CDMO decoupling could harm patients
May 9, 2024 10:00am
House lawmaker brings FDA into security crackdown on China
May 8, 2024 11:05am
Ennogen snares £30 million credit pact to fuel growth
May 8, 2024 9:10am
Sharp cuts into injectable growth with packaging plant expansion
May 7, 2024 9:29am
See More Manufacturing News